Search results for "Dysfunction"

showing 10 items of 1129 documents

Nitric oxide in the pathogenesis of vascular disease

2000

Nitric oxide (NO) is synthesized by at least three distinct isoforms of NO synthase (NOS). Their substrate and cofactor requirements are very similar. All three isoforms have some implications, physiological or pathophysiological, in the cardiovascular system. The endothelial NOS III is physiologically important for vascular homeostasis, keeping the vasculature dilated, protecting the intima from platelet aggregates and leukocyte adhesion, and preventing smooth muscle proliferation. Central and peripheral neuronal NOS I may also contribute to blood pressure regulation. Vascular disease associated with hypercholesterolaemia, diabetes, and hypertension is characterized by endothelial dysfunct…

medicine.medical_specialtyNitric Oxide Synthase Type IIIHypercholesterolemiaNitric Oxide Synthase Type IIVasodilationNitric OxideEndothelial NOSPathology and Forensic MedicineNitric oxidePathogenesischemistry.chemical_compoundInternal medicineHumansMedicineEndothelial dysfunctionbiologybusiness.industryVascular diseasemedicine.diseaseNitric oxide synthaseEndothelial stem cellOxidative StressEndocrinologychemistryCardiovascular DiseasesHypertensionbiology.proteinEndothelium VascularNitric Oxide SynthasebusinessDiabetic AngiopathiesThe Journal of Pathology
researchProduct

eNOS Uncoupling in Cardiovascular Diseases - the Role of Oxidative Stress and Inflammation

2013

Many cardiovascular diseases and drug-induced complications are associated with - or even based on - an imbalance between the formation of reactive oxygen and nitrogen species (RONS) and antioxidant enzymes catalyzing the break-down of these harmful oxidants. According to the “kindling radical” hypothesis, the formation of RONS may trigger in certain conditions the activation of additional sources of RONS. According to recent reports, vascular dysfunction in general and cardiovascular complications such as hypertension, atherosclerosis and coronary artery diseases may be connected to inflammatory processes. The present review is focusing on the uncoupling of endothelial nitric oxide synthas…

medicine.medical_specialtyNitric Oxide Synthase Type IIIInflammationOxidative phosphorylationmedicine.disease_causechemistry.chemical_compoundEnosInternal medicineDrug DiscoverymedicineHumansEndothelial dysfunctionInflammationPharmacologybiologyTetrahydrobiopterinbiology.organism_classificationmedicine.diseaseReview articleOxidative StressEndocrinologychemistryCardiovascular Diseasesmedicine.symptomAsymmetric dimethylarginineOxidative stressmedicine.drugCurrent Pharmaceutical Design
researchProduct

Cardiovascular risk and events in polycystic ovary syndrome

2009

Young women with polycystic ovary syndrome (PCOS) present a high risk for cardiovascular disease because of the presence of abdominal obesity, insulin resistance and androgen excess. In addition, they present with endothelial dysfunction and early signs of atherosclerosis (increased carotid intima-media thickness and increased coronary calcium). However, the evidence of increased cardiovascular events during the postmenopausal age is relatively small, although some recent studies have indicated a slight increase in the severity of cardiovascular disease in women who had PCOS during their fertile age. The discrepancy between cardiovascular risk in young age and postmenopausal cardiovascular …

medicine.medical_specialtyPCOS Cardiovascular risk myocardial infarction stroke atherosclerosisSettore MED/09 - Medicina InternaDiseaseAndrogen ExcessSeverity of Illness IndexSettore MED/13 - EndocrinologiaInsulin resistanceRisk FactorsInternal medicinePrevalencemedicineHumansEndothelial dysfunctionAbdominal obesityEvidence-Based Medicinebusiness.industryHyperandrogenismObstetrics and GynecologyGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareSettore MED/40 - Ginecologia E OstetriciaPolycystic ovaryPostmenopauseEndocrinologyPremenopauseCardiovascular DiseasesFemalemedicine.symptombusinessDyslipidemiaPolycystic Ovary SyndromeClimacteric
researchProduct

Role of cardiac dyssynchrony and resynchronization therapy in functional mitral regurgitation

2016

Functional mitral regurgitation (FMR) is a common complication of left ventricle (LV) dysfunction and remodelling. Recently, it has been recognized as an independent prognostic factor in both ischaemic and non-ischaemic LV dysfunctions. In this review article, we discuss the mechanisms through which cardiac dyssynchrony is involved in FMR pathophysiologic cascade and how cardiac resynchronization therapy (CRT) can have therapeutic effects on FMR by reverting specific dyssynchrony pathways. We analyse recent clinical trials focusing on CRT impact on FMR in 'real-world' patients, the limits and future perspectives that could eventually generate new predictors of CRT response in terms of FMR r…

medicine.medical_specialtyPacemaker Artificialmedicine.medical_treatmentCardiac resynchronization therapyVentricular dyssynchrony030204 cardiovascular system & hematologyCardiac resynchronization; Mitral regurgitation; Ventricular dyssynchrony; Cardiology and Cardiovascular Medicine; Radiology Nuclear Medicine and ImagingVentricular Function LeftCardiac Resynchronization Therapy03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineInternal medicineCardiac resynchronizationNuclear Medicine and ImagingmedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineVentricular remodelingVentricular dyssynchronyMitral regurgitationMitral regurgitationClinical Trials as TopicVentricular Remodelingbusiness.industryCardiac Pacing ArtificialMitral Valve InsufficiencyStroke VolumeGeneral MedicineStroke volumemedicine.diseasePrognosisReview articleEchocardiography Doppler ColorClinical trialmedicine.anatomical_structureTreatment OutcomeVentriclecardiovascular systemCardiologyRadiologybusinessCardiology and Cardiovascular MedicineRadiology
researchProduct

Focus on right ventricular outflow tract septal pacing

2013

SummaryExperimental and clinical studies have shown that right ventricular apical pacing may result in long-term deleterious effects on account of its negative impact on left ventricular remodeling through desynchronization. This risk appears more pronounced in patients with even moderate left ventricular dysfunction and generally occurs after at least 1 year of pacing. As right ventricular apical pacing may be associated with the development of organic mitral insufficiency, other sites that allow for more physiological stimulation, such as right ventricular outflow tract septal pacing, have been developed, with good feasibility and reproducibility. However, the prospective randomized studi…

medicine.medical_specialtyPacemaker Artificialmedicine.medical_treatmentHeart VentriclesCardiac resynchronization therapyStimulation infundibulaireElectric CountershockVentricular SeptumMedium termCardiac Resynchronization TherapyDefibrillatorVentricular Dysfunction LeftInternal medicineMedicineVentricular outflow tractHumanscardiovascular diseasesDéfibrillateurCardiac Resynchronization Therapy DevicesVentricular remodelingHeart FailureStimulation septaleStimulation apicaleEjection fractionbusiness.industryHazard ratioCardiac Pacing ArtificialAtrial fibrillationStroke VolumeGeneral MedicineEquipment Designmedicine.diseaseDefibrillators ImplantablePacemakerTreatment OutcomeHomogeneousInfundibular pacingAnesthesiaCardiologycardiovascular systemVentricular Function RightSeptal pacingApical pacingbusinessCardiology and Cardiovascular MedicineArchives of Cardiovascular Diseases
researchProduct

Neuroanatomical changes in early Parkinson’s disease with mild cognitive impairment: a VBM study; the Parkinson’s Disease Cognitive Impairment Study …

2021

Introduction: Mild cognitive impairment (MCI) is common in Parkinson’s disease (PD), but the underlying pathological mechanism has not been fully understood. Voxel-based morphometry could be used to evaluate regional atrophy and its relationship with cognitive performances in early PD-MCI. Patients and Methods: One hundred and six patients with PD were recruited from a larger cohort of patients, the Parkinson’s Disease Cognitive Impairment Study (PaCoS). Subject underwent a T1-3D MRI and a complete clinical and neuropsychological evaluation. Patients were divided into PD with normal cognition (PD-NC) and PD-MCI according to the MDS level II criteria–modified for PD-MCI. A subgroup of early …

medicine.medical_specialtyParkinson's diseasePrecuneusInferior frontal gyrusDermatologyNeuropsychological TestsAudiologybehavioral disciplines and activitiesVoxel-based morphometry (VBM)Angular gyrus03 medical and health sciences0302 clinical medicinemental disordersmedicineHumansCognitive DysfunctionMagnetic resonance imaging (MRI)030212 general & internal medicineGray MatterMild cognitive impairment (MCI)business.industryNeuropsychologyBrainSettore MED/37 - NeuroradiologiaGeneral MedicineFrontal gyrusmedicine.diseaseMagnetic Resonance ImagingParkinson diseasePsychiatry and Mental healthmedicine.anatomical_structurenervous systemSuperior frontal gyrusSettore MED/26 - NeurologiaNeurology (clinical)Settore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessMild cognitive impairment (MCI)030217 neurology & neurosurgeryNeurological Sciences
researchProduct

Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine

2016

In the last decades, many factors thought to be associated with the atherosclerotic process and cardiovascular events have been studied, and some of these have been shown to correlate with clinical outcome, such as arterial stiffness, endothelial dysfunction and immunoinflammatory markers. Arterial stiffness is an important surrogate marker that describes the capability of an artery to expand and contract in response to pressure changes. It can be assessed with different techniques, such as the evaluation of PWV and AIx. It is related to central systolic pressure and it is an independent predictor of cardiovascular morbidity and mortality in hypertensive patients, type 2 diabetes, end-stage…

medicine.medical_specialtyPathologyEndotheliumPopulation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineDrug DiscoverymedicineAnimalsHumansPlatelet activationEndothelial dysfunctioneducationInflammationPharmacologyeducation.field_of_studySurrogate endpointbusiness.industryCardiovascular AgentsArteriesmedicine.diseasemedicine.anatomical_structureBlood pressureCardiovascular DiseasesCardiovascular agentArterial stiffnessCardiologyEndothelium Vascularbusiness030217 neurology & neurosurgeryCurrent Pharmaceutical Design
researchProduct

Periodontitis, coronary heart disease and myocardial infarction: treat one, benefit all

2020

: Periodontal disease is conventionally defined as an inflammatory condition affecting the tissues surrounding and supporting the teeth (i.e. gum and periodontium). Recent statistics show that the prevalence of this condition is continuously growing worldwide, thus raising severe healthcare concerns, not only for local problems emerging from poor oral health, but also for the potential risk of developing systemic complications. Therefore, this article aims to provide an update on the intriguing association between periodontitis, coronary heart disease (CHD) and/or myocardial infarction (MI). Taken together, the available published information seems to support the existence of a significant …

medicine.medical_specialtyPeriodontitis coronary heart disease myocardial infarctionCoronary Artery Disease030204 cardiovascular system & hematologyOverweightCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineEpidemiologymedicineAnimalsHumansMyocardial infarctionEndothelial dysfunctioncoronary heart diseasePeriodontitisPeriodontitisbusiness.industryHematologyGeneral MedicinePeriodontiummedicine.diseaseCoronary heart diseaseTreatment Outcomemyocardial infarctionmedicine.symptomHydroxymethylglutaryl-CoA Reductase Inhibitorsbusiness030215 immunology
researchProduct

Association Between Fatigue and Cognitive Impairment at 6 Months in Patients With Ischemic Stroke Treated With Acute Revascularization Therapy.

2019

Background: Fatigue is a frequent symptom after stroke. We aimed to determine the association between fatigue and cognitive performance in patients with ischemic stroke who received acute revascularization therapy (IV thrombolysis and/or mechanical thrombectomy).Methods: Seventy patients were prospectively included in the stroke unit of the University Hospital of Dijon, France. A follow-up was performed at 6 months with clinical examination, fatigue assessment by the Fatigue Severity Scale (FSS), and a comprehensive neuropsychological evaluation. Patients with fatigue (FSS score >4) were compared with patients without fatigue. Neuropsychological factors associated with fatigue at 6 month…

medicine.medical_specialtyPhysical examinationlcsh:RC346-42903 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineischemic strokeMedicineMemory impairment030212 general & internal medicineCognitive rehabilitation therapyEffects of sleep deprivation on cognitive performanceStrokelcsh:Neurology. Diseases of the nervous systemDepression (differential diagnoses)Original Researchcognitive impairmentmedicine.diagnostic_testbusiness.industrymedicine.diseasestrokeNeurologydepressionoutcomefatigueNeurology (clinical)business030217 neurology & neurosurgeryExecutive dysfunctionFrontiers in neurology
researchProduct

Vestibular dysfunction in major depression

2007

medicine.medical_specialtyPhysical medicine and rehabilitationbusiness.industryGeneral NeurosciencemedicineVestibular dysfunctionbusinessDepression (differential diagnoses)Neuroscience
researchProduct